Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnar Brobert

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Thrombosis and Thrombolysis|May 12, 2024
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register studyMarie Linder, Anders Ekbom, Gunnar Brobert, et al.
BMJ Open|March 26, 2024
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in EuropeGunnar Brobert, Ana Ruigomez, Tania Schink, et al.
European Heart Journal|October 8, 2022
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
The Lancet. Digital Health|September 1, 2022
CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
BMJ (Clinical Research Ed.)|December 23, 2022
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Thrombosis and Thrombolysis|May 12, 2024
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register studyMarie Linder, Anders Ekbom, Gunnar Brobert, et al.
BMJ Open|March 26, 2024
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in EuropeGunnar Brobert, Ana Ruigomez, Tania Schink, et al.
European Heart Journal|October 8, 2022
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
The Lancet. Digital Health|September 1, 2022
CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
BMJ (Clinical Research Ed.)|December 23, 2022
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical researchDipak Kotecha, Folkert W Asselbergs, Stephan Achenbach, et al.
Pageof 4